Most patients with RA ‘have never heard of treat-to-target’
But an Australian survey shows there's readiness to consider the approach
Queensland researchers who surveyed patients with rheumatoid arthritis (RA) have found 91% say they have never heard of the treat-to-target approach for their condition.
And a survey of rheumatologists conducted by the same team shows that physicians see lack of time as the major barrier to using a treat-to-target approach.
